Enhabit (EHAB) Competitors

Enhabit (NYSE:EHAB) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, community ranking, institutional ownership and earnings.

Does the media prefer EHAB or AVAH?

In the previous week, Enhabit had 1 more articles in the media than Aveanna Healthcare. MarketBeat recorded 3 mentions for Enhabit and 2 mentions for Aveanna Healthcare. Enhabit's average media sentiment score of 1.01 beat Aveanna Healthcare's score of 0.26 indicating that Enhabit is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enhabit	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals hold more shares of EHAB or AVAH?

88.0% of Aveanna Healthcare shares are owned by institutional investors. 1.9% of Enhabit shares are owned by insiders. Comparatively, 7.8% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has more volatility & risk, EHAB or AVAH?

Enhabit has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500.

Do analysts rate EHAB or AVAH?

Enhabit presently has a consensus target price of $12.08, indicating a potential upside of 18.93%. Aveanna Healthcare has a consensus target price of $1.80, indicating a potential downside of 17.05%. Given Enhabit's stronger consensus rating and higher possible upside, equities research analysts clearly believe Enhabit is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enhabit	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Aveanna Healthcare	3 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Does the MarketBeat Community prefer EHAB or AVAH?

Aveanna Healthcare received 21 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 38.71% of users gave Aveanna Healthcare an outperform vote while only 13.64% of users gave Enhabit an outperform vote.

Company	Underperform	Outperform
Enhabit	Outperform Votes 3 13.64%	Underperform Votes 19 86.36%
Aveanna Healthcare	Outperform Votes 24 38.71%	Underperform Votes 38 61.29%

Is EHAB or AVAH more profitable?

Aveanna Healthcare has a net margin of -7.10% compared to Enhabit's net margin of -7.69%. Enhabit's return on equity of 1.55% beat Aveanna Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enhabit	-7.69%	1.55%	0.76%
Aveanna Healthcare	-7.10%	N/A	-1.86%

Which has better earnings and valuation, EHAB or AVAH?

Enhabit has higher earnings, but lower revenue than Aveanna Healthcare. Enhabit is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enhabit	$1.05B	0.48	-$80.50M	-$1.62	-6.23
Aveanna Healthcare	$1.90B	0.23	-$134.52M	-$0.71	-3.21

Summary

Aveanna Healthcare beats Enhabit on 9 of the 17 factors compared between the two stocks.